PTC Therapeutics, Inc.PTCTNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 124.10% |
| Q2 2025 | -107.48% |
| Q1 2025 | 1404.71% |
| Q4 2024 | 38.85% |
| Q3 2024 | -7.75% |
| Q2 2024 | -7.50% |
| Q1 2024 | 41.75% |
| Q4 2023 | -17.05% |
| Q3 2023 | 33.83% |
| Q2 2023 | -41.49% |
| Q1 2023 | 20.00% |
| Q4 2022 | -53.59% |
| Q3 2022 | 28.17% |
| Q2 2022 | -19.66% |
| Q1 2022 | 12.32% |
| Q4 2021 | -7.41% |
| Q3 2021 | -12.50% |
| Q2 2021 | 8.20% |
| Q1 2021 | -64.86% |
| Q4 2020 | -7.77% |
| Q3 2020 | 62.95% |
| Q2 2020 | -53.59% |
| Q1 2020 | -32.12% |
| Q4 2019 | -29.25% |
| Q3 2019 | -41.33% |
| Q2 2019 | 41.86% |
| Q1 2019 | -34.38% |
| Q4 2018 | 9.43% |
| Q3 2018 | -404.76% |
| Q2 2018 | 54.35% |
| Q1 2018 | -1633.33% |
| Q4 2017 | 103.66% |
| Q3 2017 | -86.36% |
| Q2 2017 | 48.24% |
| Q1 2017 | -8.97% |
| Q4 2016 | 24.27% |
| Q3 2016 | 9.65% |
| Q2 2016 | 6.56% |
| Q1 2016 | 18.67% |
| Q4 2015 | -18.11% |